as well as trans men
and nonbinary people
The Great ReadProfiles In Science
Reinventing the Uterus, One Organoid at a Time
Bioengineer Linda Griffith once grew a human ear on the back of a mouse. Now she is reframing endometriosis a “women’s disease” as a key to unlocking some of biology’s greatest secrets.
Linda G. Griffith is a professor of biological and mechanical engineering at M.I.T., and its director of the Center for Gynepathology Research. “I don’t want to make endometriosis a women’s issue,” she said in 2014. “I want to make it an M.I.T. issue.”
Endometriose: Bestimmte Inhaltsstoffe in Kosmetika könnten das Risiko erhöhen
gmx.at - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from gmx.at Daily Mail and Mail on Sunday newspapers.
Health minister announces see-and-treat gynaecology services and advanced endometriosis centre
These two health policies are recommendations from the Women’s Health Taskforce, established by the Department of Health in September 2019. By Gráinne Ní Aodha Wednesday 21 Apr 2021, 10:34 PM 4 hours ago 9,250 Views 11 Comments
Image: Shutterstock/New Africa
Image: Shutterstock/New Africa
THE MINISTER FOR Health Stephen Donnelly has announced new funding for two “key” women’s health projects – including a €641,000 investment in an endometriosis service in Dublin to focus on more complex cases.
The first is the provision of two community-based ambulatory gynaecology services, governed by two acute hospitals – Tallaght University Hospital, and University Maternity Hospital Limerick, though located in Nenagh Gen
facebook
Pintrest
The term endometriosis comes from the word endometrium , which is the uterine lining developed by your body each month in preparation for egg implantation. If a woman does not conceive within a month, the body sheds the endometrium and one gets their periods. The endometrial tissue passes through the fallopian tube and into the abdomen.
The tissue sometimes can bind to the other organs in some women. When the hormones are released during the next menstrual cycle, it causes the extra tissue to develop and then shed, much like the tissue in the uterus.
The bleeding and tissue shedding has no means of leaving the body, causing inflammation of local tissue. The discomfort felt by patients with endometriosis is often caused by inflammation.
Date Time
Share
Myovant Sciences and Pfizer Announce First Participant Dosed in Phase 3 SERENE Study Evaluating Contraceptive Efficacy of Once-Daily
SERENE is a Phase 3 single-arm, open-label study evaluating the contraceptive efficacy of investigational relugolix combination tablet in sexually active, healthy women ages 18-35 years
Contraceptive potential of relugolix combination tablet supported by prior Phase 1 study that demonstrated 100% ovulation inhibition
Data would support a potential indication of pregnancy prevention for women treated with relugolix combination tablet, if approved
BASEL, Switzerland and NEW YORK, April 12, 2021 (GLOBE NEWSWIRE) Myovant Sciences (NYSE: MYOV) and Pfizer Inc. (NYSE: PFE) today announced that the first participant has been dosed in the Phase 3 SERENE study evaluating the contraceptive efficacy of relugolix combination tablet (relugolix 40 mg, estradiol 1.0 mg, and norethindrone acetate 0.5 mg) in healthy women ages 18-35 years who are
vimarsana © 2020. All Rights Reserved.